Detection of Early Esophageal Cancer by NIR-FME.

NCT03877601 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Barrett Esophagus

Interventions

DRUG: Bevacizumab-IRDye800CW
DIAGNOSTIC_TEST: Fluorescence endoscopy

Sponsor

University Medical Center Groningen

Collaborators

[object Object]